Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline

BACKGROUND: The live attenuated 17DD Yellow Fever vaccine is one of the most successful prophylactic interventions for controlling disease expansion ever designed and utilized in larger scale. However, increase on worldwide vaccine demands and manufacturing restrictions urge for more detailed dose s...

Descripción completa

Detalles Bibliográficos
Autores principales: Campi-Azevedo, Ana Carolina, de Almeida Estevam, Paula, Coelho-dos-Reis, Jordana Grazziela, Peruhype-Magalhães, Vanessa, Villela-Rezende, Gabriela, Quaresma, Patrícia Flávia, Maia, Maria de Lourdes Sousa, Farias, Roberto Henrique Guedes, Camacho, Luiz Antonio Bastos, Freire, Marcos da Silva, Galler, Ricardo, Yamamura, Anna Maya Yoshida, Almeida, Luiz Fernando Carvalho, Lima, Sheila Maria Barbosa, Nogueira, Rita Maria Ribeiro, Silva Sá, Gloria Regina, Hokama, Darcy Akemi, de Carvalho, Ricardo, Freire, Ricardo Aguiar Villanova, Filho, Edson Pereira, Leal, Maria da Luz Fernandes, Homma, Akira, Teixeira-Carvalho, Andréa, Martins, Reinaldo Menezes, Martins-Filho, Olindo Assis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223624/
https://www.ncbi.nlm.nih.gov/pubmed/25022840
http://dx.doi.org/10.1186/1471-2334-14-391

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4223624/
https://www.ncbi.nlm.nih.gov/pubmed/25022840
http://dx.doi.org/10.1186/1471-2334-14-391

Ejemplares similares